Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714439 · ClinicalTrials.gov registry record · Early Phase 1
Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley
A Early Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 157
- Enrollment target
NCT02714439 is a Early Phase 1 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 157 participants.
The verdict
NCT02714439, a Early Phase 1 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" (HRME) for the diagnosis of cervical pre-cancerous lesions and cervical cancer. The investigators want to compare patients' clinical findings using the current equipment used in clinic with the clinical findings using new equipment we are testing on this research project. If the new equipment is proven to give comparable findings with current equipment being used, doctors might be able to offer a diagnosis and treat cervical lesions in one visit. It might not be necessary to wait for cervical biopsies to come back before women would receive the indicated treatment. Study subjects are being asked to participate because they have been diagnosed with an abnormal Papanicolaou (Pap) PAP smear, positive human papillomavirus (HPV) test or history of cervical dysplasia and need to have a colposcopic examination to determine the reason for abnormal results and receive treatment.
Interventions
- DRUG Proflavine
- PROCEDURE High-Resolution Microendoscopy (HRME)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2024-02-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02714439
The ClinicalTrials.gov registry entry for NCT02714439 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Proflavine is the first listed.
NCT02714439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02714439 about?
NCT02714439 is a clinical study titled "Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley". The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" (HRME) for the diagnosis of cervical pre-cancerous lesions and cervical cancer. The investigators want to compare patients' clinical findings using the current equipment used in cli...
What is the current status of trial NCT02714439?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 157 participants. The study started on 2016-10-25. Estimated completion is 2024-02-09.
What interventions are being tested in trial NCT02714439?
The interventions under investigation include: Proflavine (DRUG), High-Resolution Microendoscopy (HRME) (PROCEDURE).
Who is sponsoring clinical trial NCT02714439?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.